Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations

The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations

FDA clears Travere’s FILSPARI for expanded use in rare kidney disease

MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price

CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing

Nihon Kohden launches Life Scope E7 patient monitoring platform in India

CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM

Vir Biotechnology advances VIR-5500 into expansion trials in prostate cancer

Roche wins CE mark for blood-based MS brain damage test

The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain

Alexion to showcase broad neurology pipeline at AAN 2026 with 20 presentations

The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies

New guidance aims to speed up diagnosis of childhood abdominal cancers

Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours

WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat

Scientists at the forum warned of an increasingly volatile health landscape

Thermo Fisher and Singapore’s PRECISE launch major proteomics push in 100,000-person study

The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation